Congratulations to Professor Deborah Mayer for her work on The Lancet Oncology Commission on Future Research Priorities in the USA which launched on November 1st at an event on Capitol Hill and was presented on November 3 at the United Nations Association of New York Humanitarian Awards, where former Vice President Joe Biden was honored for his work on improving cancer outcomes as part of the US Cancer Moonshot Initiative.
The Lancet Oncology Commission on Future Research Priorities in the USA is authored by over 50 leading US oncologists, including members of leading US cancer organizations, and sets out 13 key priority areas, each with measurable goals, to focus the US$2 billion of funding released to the National Cancer Institute as part of the 21st Century Cures Act.
The report builds on the recommendations of the Cancer Moonshot’s Blue Ribbon Panel, of which Mayer was a member
, and sets out a detailed roadmap to accelerate cancer research. Priorities include a focus on prevention, a new model for drug discovery and development, a vast expansion of patient access to clinical trials, and an emphasis on targeted interventions to improve cancer care for underserved groups, specifically children, cancer survivors and mino rity groups. The report emphasis es the importance of addressing health disparities in all recommendations.
It highlights how technological advances, including understanding and mapping pre – cancer biology and the rapid adoption of big data, as well as new collaborations across industry, patient groups, academia, government and clinical practice will be critical to advancing research, and ultimately improving patient care.